Augment Therapy uses study results to inform software development
Our recent study, in collaboration with Parkview Health, provided valuable feedback for Augment Therapy as we work on expanding and improving our interactive games and activities. For this study, children with a BMI in the 85th – 95th percentile, ages 5-9 were encouraged to use ARWell PRO 5 days a week for two 2-week periods. Participants were free to decide when to use the app and which exercises to complete. App usage and participant feedback were collected from October through December 2025 and sent to the Augment Therapy development team.
The results of this at-home study revealed:
Children in this demographic were not sufficiently motivated to increase their activity levels with ARWell PRO.
Participants experienced frustration with motion tracking when it was not functioning optimally,
Neurotypical children ages 5-9 expressed desires for more engaging games and activities.
The Augment Therapy team responded to the results of this study by developing:
A “How to Play” tutorial to help users interact more efficiently with the motion capture software for effective gameplay, released April 2026.
“Endless Runner” gameplay – this game structure has no pre-programmed end-point, and increases in difficulty with higher levels; the game effectively ends when the player can no longer keep up with the game challenges. This game structure has been added to 3 existing games (“Obstacle Course”, “Skiing”, “Surfing”), released April 2026 with 2 more (iWall and Colorball) coming early July.
Changes to the game, “Punch Ball,” now requiring increased lateral movement for gameplay to increase the challenge, released April 2026.
“The Parkview study gave us valuable insight into how children engage with ARWell PRO at home. We’re using that feedback to shape our product roadmap, including updates that support sustained engagement and usability for a better overall experience.”
- Lisa Blake, Director of Product Augment Therapy